About BREVITEST TECHNOLOGIES, INC.
Brevitest has developed a portable, miniaturized blood analysis device capable of delivering rapid, quantitative results for multiple biomarkers and foreign substances. The technology enables on-site testing in various fields, including forensics and wellness.
Measuring multiple biomarkers from a small blood sample on one test cartridgeDelivering quantitative results in under 30 minutesRapid detection of foreign substances in blood, such as cocaine and fentanylPortable and user-friendly design, requiring no lab tech expertiseOn-site, rapid determination of drug-related causes of death in forensic applications
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to BREVITEST TECHNOLOGIES, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.